BRXC_ECOHS
ID BRXC_ECOHS Reviewed; 1213 AA.
AC P0DUF8; A0A7M3S2P3;
DT 02-JUN-2021, integrated into UniProtKB/Swiss-Prot.
DT 02-JUN-2021, sequence version 1.
DT 25-MAY-2022, entry version 3.
DE RecName: Full=Probable ATP-binding protein BrxC {ECO:0000303|PubMed:30418590};
DE AltName: Full=BREX protein BrxC {ECO:0000303|PubMed:30418590};
GN Name=brxC {ECO:0000303|PubMed:30418590}; OrderedLocusNames=EcHS_A0338;
OS Escherichia coli O9:H4 (strain HS).
OC Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC Enterobacteriaceae; Escherichia.
OX NCBI_TaxID=331112;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=HS;
RX PubMed=18676672; DOI=10.1128/jb.00619-08;
RA Rasko D.A., Rosovitz M.J., Myers G.S.A., Mongodin E.F., Fricke W.F.,
RA Gajer P., Crabtree J., Sebaihia M., Thomson N.R., Chaudhuri R.,
RA Henderson I.R., Sperandio V., Ravel J.;
RT "The pangenome structure of Escherichia coli: comparative genomic analysis
RT of E. coli commensal and pathogenic isolates.";
RL J. Bacteriol. 190:6881-6893(2008).
RN [2]
RP FUNCTION IN ANTIVIRAL DEFENSE, INDUCTION, AND DISRUPTION PHENOTYPE.
RC STRAIN=HS;
RX PubMed=30418590; DOI=10.1093/nar/gky1125;
RA Gordeeva J., Morozova N., Sierro N., Isaev A., Sinkunas T., Tsvetkova K.,
RA Matlashov M., Truncaite L., Morgan R.D., Ivanov N.V., Siksnys V., Zeng L.,
RA Severinov K.;
RT "BREX system of Escherichia coli distinguishes self from non-self by
RT methylation of a specific DNA site.";
RL Nucleic Acids Res. 47:253-265(2019).
CC -!- FUNCTION: BREX systems (bacteriophage exclusion) provide immunity
CC against bacteriophage. Part of a type 1 BREX system which protects
CC against dsDNA phage. This system allows phage adsorption but prevents
CC phage DNA replication, without degradation of the phage DNA.
CC Methylation of bacterial DNA by PglX guides self/non-self
CC discrimination. When the brxA-brxB-brxC-pglX-pglZ-brxL genes are
CC transformed into a susceptible E.coli strain (BW25113) they confer very
CC high resistance to infection by bacteriophage VR7 and VpaE1, about 100-
CC fold protection against lambda, T5 and T7 and no protection against RNA
CC phage Qbeta, ssDNA phage M13 or dSDNA phage T4 and VR5. Glycosylated
CC phage DNA is not susceptible to BREX. The BREX system does not confer
CC resistance to lysogenic lambda phage, i.e. prophage that are integrated
CC into the chromosomal DNA and then induced to form phage.
CC {ECO:0000269|PubMed:30418590}.
CC -!- INDUCTION: Transcribed at slowly increasing levels as cells progress
CC from lag to exponential to stationary phase.
CC {ECO:0000269|PubMed:30418590}.
CC -!- DISRUPTION PHENOTYPE: No methylation of 5'-GGTAAG-3' in chromosomal
CC DNA, BREX no longer confers phage resistance.
CC {ECO:0000269|PubMed:30418590}.
CC -!- SIMILARITY: Belongs to the BrxC family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP000802; ABV04726.1; -; Genomic_DNA.
DR RefSeq; WP_001019654.1; NC_009800.1.
DR AlphaFoldDB; P0DUF8; -.
DR KEGG; ecx:EcHS_A0338; -.
DR OMA; NAFEGKH; -.
DR Proteomes; UP000001123; Chromosome.
DR GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR InterPro; IPR027417; P-loop_NTPase.
DR SUPFAM; SSF52540; SSF52540; 1.
PE 1: Evidence at protein level;
KW Antiviral defense.
FT CHAIN 1..1213
FT /note="Probable ATP-binding protein BrxC"
FT /id="PRO_0000452158"
SQ SEQUENCE 1213 AA; 139272 MW; D38EA50CD5612374 CRC64;
MNIEQIFKKP LKRNINGVVK AEQTDDASAY IELDEYVITR ELENHLRHFF ESYVPATGPE
RIRMENKIGV WVSGFFGSGK SHFIKILSYL LSNRKVTHNG TERNAYSFFE EKIKDALFLA
DINKAVHYPT EVILFNIDSR ANVDDKEDAI LKVFLKVFNE RIGYCADFPH IAHLERELDK
RGQYETFKAA FADINGSRWE DERDAYYFIS DDMAQALSQA TQQSLEASRQ WVEQLDKNFP
LDINNFCQWV KEWLDDNGKN ILFMVDEVGQ FIGKNTQMML KLQTITENLG VICGGRAWVI
VTSQADINAA IGGMSSRDGQ DFSKIQGRFS TRLQLSSSNT SEVIQKRLLV KTDEAKAALA
KVWQEKGDIL RNQLAFDTTT TTALRPFTSE EEFVDNYPFV PWHYQILQKV FESIRTKGAA
GKQLAMGERS QLEAFQTAAQ QISAQGLDSL VPFWRFYAAI ESFLEPAVSR TITQACQNGI
LDEFDGNLLK TLFLIRYVET LKSTLDNLVT LSIDRIDADK VELRRRVEKS LNTLERLMLI
ARVEDKYVFL TNEEKEIENE IRNVDVDFSA INKKLASIIF DDILKSRKYR YPANKQDFDI
SRFLNGHPLD GAVLNDLVVK ILTPKDPTYS FYNSDATCRP YTSEGDGCIL IRLPEEGRTW
SDIDLVVQTE KFLKDNAGQR PEQATLLSEK ARENSNREKL LRVQLESLLA EADVWAIGER
LPKKSSTPSN IVDEACRYVI ENTFGKLKML RPFNGDISRE IHALLTVEND TELDLGNLEE
SNPDAMREVE TWISMNIEYN KPVYLRDILN HFARRPYGWP EDEVKLLVAR LACKGKFSFS
QQNNNVERKQ AWELFNNSRR HSELRLHKVR RHDEAQVRKA AQTMADIAQQ PFNEREEPAL
VEHIRQVFEE WKQELNVFRA KAEGGNNPGK NEIESGLRLL NAILNEKEDF ALIEKVSSLK
DELLDFSEDR EDLVDFYRKQ FATWQKLGAA LNGSFKSNRS ALEKDAAAVK ALGELESIWQ
MPEPYKHLNR ITLLIEQVQN VNHQLVEQHR QHALERIDAR IEESRQRLLE AHATSELQNS
VLLPMQKARK RAEVSQSIPE ILAEQQETKA LQMDADKKIN LWIDELRKKQ EAQLRAANEA
KRAAESEQTY VVVEKPVIQP VPKKTHLVNV ASEMRNATGG EVLETTEQVE KALDTLRTTL
LAAIKAGDRI RLQ